Article Text

Download PDFPDF
E-060 Does stent type impact coil embolization outcomes in extended follow-up of small-sized aneurysms (<10mm)?
  1. Y Cho,
  2. H Kang,
  3. M Han
  1. Radiology, Seoul National University Hospital, Seoul, Korea, Republic Of

Abstract

Background and Purpose Self-expandable stents have enabled endovascular treatment of wide-necked aneurysms (ordinarily viewed as technically prohibitive), with favorable outcomes. However, the impact of stent type on occlusive stability has not been adequately investigated. In small-sized saccular aneurysms, we generated estimates of stent-assisted coil embolization outcomes during follow-up monitoring. Stent type and other risk factors linked to recanalization were analyzed.

Methods A cohort of 289 patients harboring 315 small-sized aneurysms (<10 mm) was subjected to mid-term and extended follow-up monitoring after stent-assisted coiling. Three types of stents (Enterprise, 195; Neuroform, 27; LVIS, 93) were deployed in this population, all medical records and radiologic data of which were reviewed. Mid-term recanalization rates and related risk factors were assessed using binary logistic regression analysis.

Results A total of 49 aneurysms (15.6%) displayed recanalization at 6 months postembolization, with 34 and 15 instances of minor and major recanalization, respectively. Multivariate analysis indicated that wide-necked aneurysms (>4 mm) (HR=2.309; p=0.020), incomplete occlusion at time of coiling (HR=2.688; p=0.004), and stent type (p=0.045) were significant factors in mid-term recanalization; whereas hypertension (p=0.123) and packing density ≤30% (p=0.167) fell short of statistical significance. Compared with Enterprise (HR=2.735) or Neuroform (HR=4.410) stents, outcomes proved more favorable with use of LVIS.

Conclusions Above findings demonstrate that in addition to occlusive status at time of coil embolization and neck size, stent type may affect follow-up outcomes of stent-assisted coil embolization in small-sized aneurysms. LVIS (vs Enterprise or Neuroform stents) performed best during follow-up monitoring in terms of limiting recanalization.

Disclosures Y. Cho: None. H. Kang: None. M. Han: None.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.